Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Idun Pharmaceuticals completes private placement

Executive Summary

Idun Pharmaceuticals (develops drug candidates to control apoptosis) completed a $22.8mm private placement of preferred stock led by Ventana Capital Management. New investors GeneChem Management, Hambrecht and Quist Capital Management (HQCM), RBC Capital Partners, BioVeda Capital, and Sorrento Associates were joined by returning investors Venrock Associates and Arch Venture Partners.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies